Mindfulness training for cognitive impairment in people experiencing psychosis

Integrated Rehabilitation Treatment enhanced with mindfulness compared with Integrated Rehabilitation Treatment in people with schizophrenia spectrum disorders: Effects over executive functions and theory of mind skills

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN52873519

Enrollment

Registered

2017-10-16

Start date

2013-08-01

Completion date

Unknown

Last updated

2023-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia disorder and schizophrenia-related disorders following DSM-IV criteria Mental and Behavioural Disorders Schizophrenia disorder and schizophrenia-related disorders

Interventions

Participants contacted by their regular psychiatrist to perform an interview to be informed about mindfulness and what participation in the trial would involve as well to assess eligibility. At the en

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Age between 18-65 2. Diagnosis of schizophrenia or schizoaffective disorder 3. No changes in psychiatric medication or hospitalization in last month 4. Have signed informed consent 5. Be able to understand and read Spanish language 6. Any gender

Exclusion criteria

Exclusion criteria: 1. Significant cognitive impairment 2. Inability to attend mindfulness sessions 3. Posed a risk of violence to the researchers 4. Refused to participate or to sign informed consent

Design outcomes

Primary

Measure	Time frame
1. Executive Functions are measured using the Trail Making Test, Stroop Test, Digits from WAIS-III, and the Controlled Oral Word Association Test at baseline and 26 weeks. 2. Theory of Mind is measured using the Hinting Test and the Reading the Mind in the Eyes Test at baseline and 26 weeks 3. General mindfulness awareness in daily life as a consequence of treatment are assessed by Mindfulness Attention Awareness Scale (MAAS) at baseline and 26 weeks	—

Measure

Time frame

1. Executive Functions are measured using the Trail Making Test, Stroop Test, Digits from WAIS-III, and the Controlled Oral Word Association Test at baseline and 26 weeks. 2. Theory of Mind is measured using the Hinting Test and the Reading the Mind in the Eyes Test at baseline and 26 weeks 3. General mindfulness awareness in daily life as a consequence of treatment are assessed by Mindfulness Attention Awareness Scale (MAAS) at baseline and 26 weeks

—

Secondary

Measure	Time frame
1. Symptoms are measured using videotapped Positive and Negative Syndrome Scale at baseline and 26 weeks 2. Demographic information is measured using clinical record form at baseline	—

Countries

Spain

Contacts

Public ContactEnric Munar

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026